A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults
Clinical trial NCT04871113 · COMPLETED
Trial details
- NCT number
- NCT04871113
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-22
- Primary completion
- 2022-10-27
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.